AGIOS PHARMACEUTICALS INC — Form D
AGIOS PHARMACEUTICALS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-22. The offering totals $78.0M, of which $78.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-11-22
- Form: D
- Accession: 0001439222-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $78.0M
- Amount sold: $78.0M
- Investors: 19
- Date of first sale: 2011-11-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-169115
Issuer
- Name: AGIOS PHARMACEUTICALS INC
- CIK: 0001439222
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 38 Sidney Street, CAMBRIDGE, MA, 02139
- Phone: 617-272-5275
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Lewis C Cantley | Director | Cambridge, MA |
| Doug Cole | Director | Culver City, CA |
| Perry C Karsen | Director | Cambridge, MA |
| John C Maraganore | Director | Cambridge, MA |
| Robert Nelsen | Director | Seattle, WA |
| David Schenkein | Director | Cambridge, MA |
| Kevin C Starr | Director | Cambridge, MA |
| Marc C Tessier-Lavigne | Director | Cambridge, MA |
| Duncan Higgons | Executive Officer | Cambridge, MA |
| David Schenkein | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More